FDA药品溶出方法数据库
(FDA-Recommended Dissolution Methods Database)
药品通用名称 剂型 USP溶出装置 速度 溶出介质 介质体积 建议取样时间(分钟) 更新日期
Nateglinide Tablet II (Paddle) 50 0.01 N HCl with 0.5% (w/v) SLS 1000 10, 20, 30 and 45 2007/01/03
Nebivolol HCl Tablet II (Paddle) 50 0.01 N HCl 900 10, 20, 30 and 45 2010/01/15
Nebivolol/Valsartan Tablet I (Basket) 100 67 mM Phosphate Buffer pH 6.8 with 0.5% SDS 900 5, 10, 15, 20 and 30 2016/10/20
Nefazodone HCl Tablet II (Paddle) 50 0.1 N HCl 900 10, 20, 30, 45 and 60 2007/01/03
Nelfinavir Mesylate Tablet II (Paddle) 50 0.1 N HCl 900 5, 10, 15, 20, 30, 45, 60 and 90 2007/01/03
Nelfinavir Mesylate Powder for Suspension II (Paddle) 50 0.1 N HCl 900 5, 10, 15, 20, 30, and 45 2007/09/13
Neomycin Sulfate Tablet II (Paddle) 50 0.05 M Phosphate Buffer, pH 6.8 900 15, 30, 45 and 60 2008/01/14
Nepafenac Ophthalmic Suspension Develop a method to characterize in vitro release 2014/08/14
Nerandomilast Tablet II (Paddle) 50 0.001 N HCl 900 5, 10, 15, 20, 30, 45 and 60 2026/03/25
Neratinib Maleate Tablet II (Paddle) 50 0.1 N HCl 900 5, 10, 15, 20, 30, 45 and 60 2026/01/28
Netupitant/Palonosetron HCl Capsule II (Paddle) Netupitant:100; Palonosetron: 75 Netupitant: 0.07M Phosphate buffer pH 6.8 containing 1% sodium SDS ; Palonosetron: 0.01 N HCl Netupitant: 900; Palonosetron: 500 Netupitant: 10, 20, 30, 45, 60 and 75; Palonosetron: 5, 10, 15, 20, 30 and 45 2015/09/03
Nevirapine Tablet (Extended Release) I (Basket) 75 0.04 M Sodium phosphate buffer pH 6.8 containing 2% sodium lauryl sulfate 900 1, 2, 3, 4, 5, 6, 8, 10, 12, 16 and 20 hours 2013/01/31
Nevirapine Suspension II (Paddle) 25 0.1 N HCl 900 10, 20, 30, 45 and 60 2004/02/11
Nevirapine Tablet Refer to USP 2007/09/13
Niacin Tablet (Extended Release) Develop a dissolution method 2023/09/15
Niacin/Simvastatin Tablet (Extended Release) Simvastain: I (10 mesh rotating Basket) 100 Niacin: Develop a dissolution method; Simvastatin: 0.5 % SDS in 0.01 M Sodium Phosphate, pH 7.0 900 Simvastatin: 10, 20, 30, 45 and 60 2023/09/15
Nicardipine HCl Capsule II (Paddle) 50 0.033 M Citric Acid Buffer, pH 4.5 900 10, 20, 30 and 45 2004/02/11
Nicardipine HCl Capsule (Extended Release) II (Paddle) 50 0.1 N HCl 1000 0.5 , 2 and 6 hours 2008/07/14
Nicotine Film, Extended Release Develop a dissolution method 2024/01/03
Nicotine Polacrilex Lozenge (Mini) III (Reciprocating Cylinder) 20 dpm Phosphate buffer pH 7.4 250 15, 30, 45, 60 and 90 2017/03/09

数据库说明:

当前数据更新日期:2026年04月22日。
©2006-2026 DrugFuture->FDA-Recommended Dissolution Methods Database